The Cancer Biologics Market has emerged as a cornerstone in modern oncology, offering targeted and highly effective therapeutic options. Biologics, derived from living organisms, are designed to specifically target cancer cells, leading to improved patient outcomes and reduced systemic toxicity compared to traditional chemotherapy. The market's robust growth is primarily fueled by the...